|
||||
 |
||||
|
|
|
|
 |
|
|
||||||||||||||||||
 |
Track RecordSince its inception in 1995, InCube Laboratories has incubated 14 medical device companies – financed to date by approximately $210 million of investment capital. The first 6 ventures have already exited, returning $790 million, while the more recent 8 ventures are continuing to grow and create value.Prior to the formation of InCube Labs, Mir founded a series of successful companies built around innovations in Healthcare. These successes include the first Implantable Defibrillator, Embolic Protection during interventional procedures, as well as Trans Urethral Needle Ablation (Tuna) used to treat Benign Prostate Hyperplasia on an outpatient basis. |
 |
|||||
 |
|
 |
|||
 |
 |